Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Common Equity (2020 - 2026)

Updated

Rallybio (RLYB) posted Common Equity of $92.3 million for Q3 2026, up 46.4% from $63.03 million a year earlier but down 2.3% from the prior quarter.

Analysis

Rallybio (RLYB) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Rallybio's Common Equity came in at $57.96 million, down 6.0% from FY2024.

  • Annual Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -15.7% (FY2020 to FY2025).
  • In prior years, Rallybio's Common Equity was $61.65 million in FY2024 (-41.9%), $106.18 million in FY2023 (-37.3%), $169.32 million in FY2022 (-3.6%) and $175.6 million in FY2021 (+29.1%).
  • Quarterly Common Equity has run from a low of $45.96 million in Q2 2025 to a high of $175.6 million in Q4 2021 over five years.
  • On a year-over-year basis, Common Equity increased in two of the last eight quarters, with growth averaging 0.5%.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 105.6%; the weakest was Q3 2024, with a decline of 42.7%.
  • According to Business Quant data, Common Equity for the three prior quarters was $94.5 million (Q2 2026), $50.28 million (Q1 2026) and $57.96 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 81.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -4.58 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 51.81 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 13.04 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 89.30 Bn
10 Rallybio 84.05 Mn -201.02 Mn - 92.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 92.30 Mn
Jun 30, 2026 94.50 Mn
Mar 31, 2026 50.28 Mn
Dec 31, 2025 57.96 Mn
Sep 30, 2025 63.03 Mn
Jun 30, 2025 45.96 Mn
Mar 31, 2025 54.07 Mn
Dec 31, 2024 61.65 Mn
Sep 30, 2024 70.82 Mn
Jun 30, 2024 80.02 Mn
Mar 31, 2024 89.16 Mn
Dec 31, 2023 106.18 Mn
Sep 30, 2023 123.58 Mn
Jun 30, 2023 139.26 Mn
Mar 31, 2023 155.20 Mn
Dec 31, 2022 169.32 Mn
Sep 30, 2022 131.94 Mn
Jun 30, 2022 147.85 Mn
Mar 31, 2022 163.04 Mn
Dec 31, 2021 175.60 Mn
API Access

Rallybio Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=RLYB&period=max&api_key=YOUR_API_KEY